Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015
December 12, 2019
Aptinyx to Present at 38th Annual J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)
December 09, 2019
Aptinyx to Present Preclinical Data Exhibiting Effects of NYX-783 in Models of PTSD and Alcohol Use Disorder at the American College of Neuropsychopharmacology’s Annual Meeting
Download PDF format download (opens in new window)
December 05, 2019
Aptinyx Initiates Phase 2 Study of NYX-458 in Patients with Mild Cognitive Impairment Associated with Parkinson’s Disease
Download PDF format download (opens in new window)
November 14, 2019
Aptinyx to Present at Upcoming Investor Conferences
Download PDF format download (opens in new window)
November 12, 2019
Aptinyx Initiates Two Phase 2 Studies of NYX-2925 in Patients with Chronic Centralized Pain Conditions
Download PDF format download (opens in new window)
November 12, 2019
Aptinyx Reports Third Quarter 2019 Financial Results and Highlights
Download PDF format download (opens in new window)
November 05, 2019
Aptinyx to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
Download PDF format download (opens in new window)
October 28, 2019
Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting
Download PDF format download (opens in new window)
October 15, 2019
Aptinyx to Present Preclinical Data on Three Clinical-Stage NMDA Receptor Modulators at the 49th Annual Meeting of the Society for Neuroscience
Download PDF format download (opens in new window)
September 30, 2019
Aptinyx to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
Download PDF format download (opens in new window)
September 26, 2019
Three Recent Preclinical Publications Highlight NMDA Receptor Activation Facilitated by Aptinyx’s NYX-2925
Download PDF format download (opens in new window)
September 04, 2019
Former Principal Deputy Commissioner of FDA, Dr. Rachel Sherman, Joins Aptinyx Board of Directors
Download PDF format download (opens in new window)
August 21, 2019
Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury
Download PDF format download (opens in new window)
August 12, 2019
Aptinyx Reports Second Quarter 2019 Financial Results and Highlights
Download PDF format download (opens in new window)
August 06, 2019
Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference
Download PDF format download (opens in new window)
August 05, 2019
Aptinyx to Report Second Quarter 2019 Financial Results on Monday, August 12, 2019
Download PDF format download (opens in new window)
July 12, 2019
Aptinyx Salutes Retiring Chief Scientific Officer and NMDA Receptor Drug Discovery Pioneer, Joseph Moskal
Download PDF format download (opens in new window)
June 26, 2019
Aptinyx Presents Preclinical Data Demonstrating Robust Activity of NYX-783 on Alcohol-Seeking Behavior and Relapse-Like Behavior in Multiple Models of Alcohol Use Disorder
Download PDF format download (opens in new window)
June 18, 2019
Aptinyx to Present at the 2019 BMO Prescription for Success Healthcare Conference
Download PDF format download (opens in new window)
June 10, 2019
Aptinyx Reports Positive Top-line Data from Phase 2 Study of NYX-2925 in Patients with Fibromyalgia, Demonstrating Significant Effects on Both Biomarkers and Patient-Reported Pain
Download PDF format download (opens in new window)
May 14, 2019
Aptinyx Reports First Quarter 2019 Financial Results and Provides Corporate Update
Download PDF format download (opens in new window)
May 07, 2019
Aptinyx Appoints Henry Gosebruch to Its Board of Directors
Download PDF format download (opens in new window)
May 06, 2019
Aptinyx to Report First Quarter 2019 Financial Results on Tuesday, May 14, 2019
Download PDF format download (opens in new window)
April 30, 2019
Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers
Download PDF format download (opens in new window)
April 18, 2019
Robust Analgesic Activity of Aptinyx’s NYX-2925 in Advanced DPN Patients Revealed Through Further Analysis of Data from Phase 2 Study
Download PDF format download (opens in new window)
April 04, 2019
Aptinyx to Present at 18th Annual Needham Healthcare Conference
Download PDF format download (opens in new window)
April 03, 2019
Data in Parkinson’s Disease Model in Non-human Primates Demonstrate Reversal of Cognitive Deficits with Novel NMDA Receptor Modulator, NYX-458
Download PDF format download (opens in new window)
March 28, 2019
Aptinyx to Present Detailed Results from Phase 2 Painful DPN Study of NYX-2925 at American Pain Society Scientific Meeting
Download PDF format download (opens in new window)
March 22, 2019
Aptinyx to Present Preclinical Data on NYX-458 at the AD/PD 14th International Conference on Alzheimer’s & Parkinson’s Diseases
Download PDF format download (opens in new window)
March 21, 2019
Aptinyx Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress
Download PDF format download (opens in new window)
March 14, 2019
Aptinyx to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 21, 2019
Download PDF format download (opens in new window)
March 06, 2019
Aptinyx to Present at Cowen and Company 39th Annual Health Care Conference
Download PDF format download (opens in new window)
February 22, 2019
Aptinyx to Present at 8th Annual SVB Leerink Global Healthcare Conference
Download PDF format download (opens in new window)
February 19, 2019
Aptinyx Initiates Phase 2 Study to Evaluate Safety and Efficacy of NYX-783 in Patients with Post-Traumatic Stress Disorder
Download PDF format download (opens in new window)
January 16, 2019
Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
Download PDF format download (opens in new window)
January 02, 2019
Aptinyx to Present at 37th Annual J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)